. Author manuscript; available in PMC: 2015 Jan 11.

Published in final edited form as: Curr Geriatr Rep. 2014 Jul 8;3(3):182–189. doi: 10.1007/s13670-014-0095-4

Table 1.

Validated screening tools in geriatric oncology

Screening Tool	Components	Data in Community-dwelling older adults	Data in older oncology patients
VES-13^42,43	•Age •Self-rated health status •Functional capacity •Physical performance	Predictive of increased risk of death or functional decline in next two^44,45 years	Demonstrated high predictive value for identifying impairment on more comprehensive geriatric assessment^13,46
GFI⁴⁷	•Physical fitness •Vision and hearing •Weight loss •Polypharmacy •Self-reported memory loss •Psychosocial functioning	GFI score correlated with results of more comprehensive geriatric^48,49 assessment	Patients with higher baseline GFI scores had increased mortality rate after initiating treatment with chemotherapy⁵⁰
G8	•Nutrition •Mobility •Cognition •Polypharmacy •Self-rated health status	None	Predictive of deficits on more comprehensive geriatric assessment (sensitivity=76.6%)⁵¹

VES-13 – Vulnerable Elders Survey-13; GFI – Groningen Frailty Indicator